VAXIL BIO LTD. Announced that Dr. Michael Berelowitz has been appointed as special advisor to its board. Dr. Michael Berelowitz, formerly Pfizer's Head of Clinical Development and Medical Affairs (Specialty Care), has enjoyed a 50+ year career in the biomedical sciences across the clinical practice of medicine, basic and clinical research and teaching, along with senior responsibilities in administration, budget management, and people leadership in academia and pharmaceutical companies/industry settings. Michael has also served on company boards, including public companies.